ERBB2 and neoplasm: Taken together, these data suggest that although AIT promotes the infiltration of CD8+ T cells, the highly proliferative nature of the metastatic tumors may evade such anti-tumor immune responses by emerging with reduced expression of the tumor antigen, neu.